Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote ()	8/18/1999 3:01:00 PM
From: Mozart	Read Replies (2) of 4974

Check this out. A small biotech company in Hudson, Ohio (Zaxis, OTC bulletin board ZAXS) just announced that they have been given an exlusive right for distribution of a Malaria drug developed by a company called Vaccine Solutions Ltd. out of Queensland, Australia...the stock is trading for a buck or a buck and a quarter...only 6 million shares total outstanding....the drug is under going "human" tests on the island of Borneo in 6 weeks and get this...vaccine solutions has already invested 50 + million in this drug. If this drug works...the stock is a 200 to 500 stock and then up! Strange situation. If you'd like to be put on a e-mail list for updates on this unusual situation...please e-mail me at mozart9999@hotmail.com and I'll make sure you get up-to-date stuff on what is going on. Mozart

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next